Women Researcher Award
Jana K. Al Wattar
Lebanese International University, Lebanon
Jana K. Al Wattar is a Lebanese pharmaceutical scientist, academic researcher, and Assistant Professor specializing in pharmaceutical sciences, nanotechnology-based drug delivery systems, and translational nanomedicine. Her research primarily focuses on smart lipid-based nanocarriers for cancer therapeutics and neurodegenerative disorders, with emphasis on enhancing therapeutic efficacy, improving drug bioavailability, and overcoming multidrug resistance mechanisms.[1]
Over more than a decade of academic and professional engagement, Dr. Al Wattar has contributed extensively to pharmaceutical education, interdisciplinary nanomedicine research, and international scientific collaboration. Her work integrates pharmaceutical technology, nanotechnology, biotechnology, and biomedical innovation through collaborative partnerships across Lebanon, the Gulf region, and international academic institutions.[2]
Abstract
Jana K. Al Wattar has established a distinguished research profile in pharmaceutical sciences with specialization in nanotechnology-based therapeutic delivery systems for oncology and neurological disorders. Her scientific contributions encompass the formulation, optimization, and characterization of smart nanocarriers, including nanovesicles, nanosponge systems, liposomal nanohybrids, electrohydrodynamic nanofibers, and stimuli-responsive drug delivery platforms.[3]
Her work demonstrates interdisciplinary integration of pharmaceutical technology, nanomedicine, biomaterials, and translational therapeutics. In addition to publishing in internationally recognized journals, she has actively contributed to scientific conferences, secured competitive research grants, supervised collaborative projects, and established institutional research partnerships across the Middle East and beyond.[4]
Keywords
Nanomedicine; Pharmaceutical Technology; Drug Delivery Systems; Lipid Nanocarriers; Cancer Therapeutics; Neurodegenerative Disorders; Smart Nanovesicles; Nanotechnology; Biomaterials; Pharmaceutical Biotechnology; Liposomal Systems; Targeted Drug Delivery; Tissue Engineering; Translational Medicine; Pharmaceutical Sciences
Introduction
Advances in nanotechnology and pharmaceutical sciences have transformed the development of targeted therapeutic systems for complex diseases including cancer and neurodegenerative disorders. Researchers in pharmaceutical nanotechnology contribute significantly to improving therapeutic outcomes through innovative drug delivery systems that enhance bioavailability, stability, specificity, and patient safety. Dr. Jana K. Al Wattar has contributed to this evolving field through sustained academic research focused on nanocarrier engineering, smart drug delivery systems, and translational pharmaceutical applications.[5]
Her research vision aims to establish a translational nanomedicine platform in the Levant region that addresses unmet therapeutic challenges associated with drug resistance, poor bioavailability, and targeted treatment delivery. Her academic and scientific activities demonstrate commitment to regional research development, scientific leadership, and interdisciplinary collaboration.
Research Profile
Dr. Al Wattar currently serves as a Full-time Assistant Professor in the Department of Pharmaceutical Sciences at Lebanese International University in Beirut, Lebanon. Her teaching portfolio includes pharmaceutics, dosage forms, pharmaceutical calculations, physical pharmacy, compounding laboratories, biotechnology laboratories, and pharmacy practice experience courses.
Her academic experience spans more than twelve years in higher education, during which she has contributed to undergraduate and postgraduate mentorship, pharmaceutical curriculum development, and scientific supervision. Prior to her current appointment, she served as Lecturer Assistant at Beirut Arab University and Instructor at Lebanese International University.
Her doctoral studies in Pharmaceutical Technology and Industrial Pharmacy at Beirut Arab University focused on innovative nanotechnology-based formulations and advanced pharmaceutical delivery systems. Her academic trajectory has consistently emphasized pharmaceutical innovation and translational therapeutic applications.
Research Contributions
Dr. Al Wattar has contributed substantially to nanomedicine research through development and optimization of advanced drug delivery systems. Her investigations focus on enhancing therapeutic efficacy while minimizing toxicity through rational nanocarrier design and smart pharmaceutical engineering strategies.
- Development of lipid-based nanocarriers for targeted cancer therapeutics.
- Optimization of nanovesicle systems for neurological and neuroinflammatory disorders.
- Investigation of smart stimuli-responsive liposomal nanohybrid systems for theranostic applications.
- Research on electrohydrodynamic atomization for fast-dissolving drug delivery systems.
- Studies involving thymoquinone-loaded nanosystems for oxidative stress modulation and anticancer activity.
- Collaborative interdisciplinary projects involving biomaterials, tissue engineering, and pharmaceutical biotechnology.
Her collaborative network extends across leading institutions in Lebanon, the United Arab Emirates, Jordan, and Egypt, demonstrating active international scientific engagement in pharmaceutical nanotechnology and translational biomedical sciences.
Publications
Jana K. Al Wattar has authored and co-authored numerous peer-reviewed publications in pharmaceutical sciences, nanomedicine, and drug delivery research. Her scholarly work focuses on lipid nanovesicles, smart nanocarriers, cancer therapeutics, neurodegenerative disorders, and pharmaceutical biotechnology, contributing to advancements in targeted drug delivery systems and translational pharmaceutical innovation.
Research Impact
Dr. Al Wattar’s research contributes to advancing pharmaceutical nanotechnology and translational medicine in the Middle East region. Her work on smart nanocarrier systems addresses critical biomedical challenges related to targeted therapy, controlled drug release, and therapeutic optimization.
Her scholarly contributions have been recognized through multiple academic distinctions, including research grants, best oral presentation awards, poster awards, and competitive doctoral scholarships. These recognitions reflect sustained engagement in innovative pharmaceutical research and academic leadership.
Beyond publications, her impact is evident in scientific mentorship, supervision of institutional collaborations, and active involvement in regional capacity-building initiatives related to pharmaceutical sciences and biomedical innovation.
Award Suitability
Dr. Jana K. Al Wattar demonstrates qualifications aligned with the criteria of an Outstanding Researcher Award through her interdisciplinary scientific contributions, international collaborations, research leadership, and commitment to pharmaceutical innovation.
- Extensive expertise in nanotechnology-based drug delivery systems.
- Strong publication profile in pharmaceutical and nanomedicine journals.
- Leadership in regional and international collaborative research initiatives.
- Successful acquisition of competitive research grants and academic awards.
- Long-standing commitment to pharmaceutical education, mentorship, and scientific capacity building.
Conclusion
Dr. Jana K. Al Wattar represents a significant emerging voice in pharmaceutical nanotechnology and translational drug delivery research. Her academic profile combines innovative scientific investigation, interdisciplinary collaboration, educational leadership, and regional research development. Through sustained contributions to nanomedicine, targeted therapeutics, and pharmaceutical sciences, she continues to strengthen scientific advancement within the Levant region and the broader international biomedical research community.
External Links
References
- Lebanese International University. (2026). Faculty profile of Dr. Jana K. Al Wattar.
- Beirut Arab University. (2025). Academic and research activities in pharmaceutical sciences.
- Alwattar, J.K., et al. (2021). Smart stimuli-responsive liposomal nanohybrid systems: A critical review of theranostic behavior in cancer. Pharmaceutics.
- AAU Health & Biomedical Symposium. (2024). Conference awards and scientific participation records.
- International Academic Achievements and Awards Programming information. International Academic Achievements & Awards